Pine Bridge Investments, L.P. Abbott Laboratories Transaction History

Pine Bridge Investments, L.P.

$13.1 Billion
Q3 2024

A detailed history of Pine Bridge Investments, L.P. transactions in Abbott Laboratories stock. As of the latest transaction made, Pine Bridge Investments, L.P. holds 469,873 shares of ABT stock, worth $55.3 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

469,873

Previous 549,537 14.5%

Holding current value

$55.3 Million

Previous $57.1 Million 6.19%

% of portfolio

0.41%

Previous 0.47%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $7.97 Million - $9.41 Million	-79,664 Reduced 14.5%	469,873 $53.6 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $27.6 Million - $30.9 Million	274,465 Added 99.78%	549,537 $57.1 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $2.29 Million - $2.53 Million	-20,878 Reduced 7.05%	275,072 $31.3 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $6.74 Million - $8.25 Million	-74,739 Reduced 20.16%	295,950 $32.6 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $17.2 Million - $20.6 Million	179,899 Added 94.29%	370,689 $35.9 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $43.6 Million - $48.6 Million	-432,832 Reduced 69.41%	190,790 $20.8 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $28.5 Million - $33.6 Million	294,400 Added 89.42%	623,622 $63.1 Million
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $272,251 - $319,393	2,864 Added 0.88%	329,222 $36.2 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $19.6 Million - $22.7 Million	-202,229 Reduced 38.26%	326,358 $31.6 Million
Q2 2022 Aug 05, 2022	BUY	$102.07 - $123.37 $11.9 Million - $14.4 Million	117,062 Added 28.45%	528,587 $57.4 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $6.56 Million - $8 Million	57,545 Added 16.26%	411,525 $48.7 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $7.57 Million - $9.27 Million	-65,511 Reduced 15.62%	353,980 $49.8 Million
Q3 2021 Nov 09, 2021	BUY	$116.66 - $129.06 $1.4 Million - $1.55 Million	12,026 Added 2.95%	419,491 $49.6 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $2.43 Million - $2.86 Million	22,959 Added 5.97%	407,465 $47.2 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $8.24 Million - $9.71 Million	75,712 Added 24.52%	384,506 $46.1 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $7.36 Million - $8.02 Million	70,113 Added 29.38%	308,794 $33.8 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $1.96 Million - $2.38 Million	-21,366 Reduced 8.22%	238,681 $26 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $704,673 - $901,894	-9,203 Reduced 3.42%	260,047 $23.8 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $1.75 Million - $2.56 Million	27,861 Added 11.54%	269,250 $21.2 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $1 Million - $1.11 Million	12,750 Added 5.58%	241,389 $21 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $1.16 Million - $1.26 Million	14,211 Added 6.63%	228,639 $19.1 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $10.4 Million - $12.1 Million	142,609 Added 198.57%	214,428 $18 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $61,054 - $73,815	-922 Reduced 1.27%	71,819 $5.74 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $2.94 Million - $3.33 Million	-44,901 Reduced 38.17%	72,741 $5.26 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $4.49 Million - $5.41 Million	73,766 Added 168.12%	117,642 $8.63 Million
Q2 2018 Aug 09, 2018	BUY	$57.57 - $63.54 $2.02 Million - $2.23 Million	35,078 Added 398.7%	43,876 $2.68 Million
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $495,063 - $559,728	8,798 New	8,798 $527,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.

Account

Pine Bridge Investments, L.P. Abbott Laboratories Transaction History